Lyon, France – October 7th, 2014 – Solvay Aroma Performance showcases at CPHI 2014 its brand-new ID3 unique open innovation model to develop customized molecules, and especially pharmaceuticals starting materials. This innovative business model is today on the podium for the CPHI Innovation in Partnering category, new category promoted by the CPHI experts.
“We are very proud to be on the podium. The Innovation in partnering category highlights both ID3 innovative purpose and our customers’ intimacy from the early stage of their developments, which are the pillars of our business model.” says Christophe Gas, WW Performance Solutions Business Director.
ID3 model is built on dedicated resources and Solvay diphenols and fluorinated fully integrated core technologies together with its historical pharmaceutical and agrochemical expertise. New customer building blocks requests can thus be promptly addressed thanks to a well-defined internal methodology. “From the early step of the innovative process, our experts work closely with customers to analyse feasibility, manage sampling and pilots to ramp up and industrialization” adds Vanessa Gambin-Mathias, ID3 business Manager.
This ID3 new process design impulses agility and efficiency within all the stages of the project development, with stronger impact once integrated from the early beginning of the R&D step.
In addition to this unique collaborative model, Solvay Aroma Performance showcases during CPHI its full range of products and solutions to support the stringent pharma requirements and growth through its competitive and sustainable offer. Its starting raw materials for APIs benefit strongly from the unique upstream industrial integration and pharmaceutical constraints knowledge.
Our team of experts welcome you at our Solvay booth 3G85 in Hall 3 to further present our full range of building blocks and the ID3 innovative business model.
***
More information on WWW.SOLVAY.COM
Follow us on twitter @SolvayGroup
***
SOLVAY AROMA PERFORMANCE is the world leader in the production and sale of specialty fluoroaliphatic derivatives. Through its Performance Solutions division, Solvay offers intermediates and solutions for the agrochemicals, pharmaceuticals and electronic markets.
As an international chemical group, SOLVAY assists industries in finding and implementing ever more responsible and value-creating solutions. Solvay generates 90% of its net sales in activities where it is among the world's top three players. It serves many markets, varying from energy and the environment to automotive and aeronautics or electricity and electronics, with one goal: to raise the performance of its clients and improve society's quality of life. The group is headquartered in Brussels, employs about 29,400 people in 56 countries and generated 9.9 billion euros in net sales in 2013. Solvay SA is listed as SOLB.BE on NYSE Euronext in Brussels and Paris (Bloomberg: SOLB:BB - Reuters: SOLB.BR).
